The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(1H-tetrazol-5-yl)phenyl)-5,6,7,8-tetrahydronaphthalene-1-carboxamide ID: ALA4745401
Chembl Id: CHEMBL4745401
PubChem CID: 162647842
Max Phase: Preclinical
Molecular Formula: C18H17N5O
Molecular Weight: 319.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccccc1-c1nnn[nH]1)c1cccc2c1CCCC2
Standard InChI: InChI=1S/C18H17N5O/c24-18(14-10-5-7-12-6-1-2-8-13(12)14)19-16-11-4-3-9-15(16)17-20-22-23-21-17/h3-5,7,9-11H,1-2,6,8H2,(H,19,24)(H,20,21,22,23)
Standard InChI Key: PBTHRRXFEPIPBD-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 319.37Molecular Weight (Monoisotopic): 319.1433AlogP: 3.00#Rotatable Bonds: 3Polar Surface Area: 83.56Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.16CX Basic pKa: ┄CX LogP: 3.80CX LogD: 2.20Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: -1.62
References 1. Iwaki Y,Yashiro K,Kokubo M,Mori T,Wieting JM,McGowan KM,Bridges TM,Engers DW,Denton JS,Kurata H,Lindsley CW. (2019) Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249., 29 (13.0): [PMID:31072652 ] [10.1016/j.bmcl.2019.04.048 ]